D3 dopamine receptor and essential hypertension

Current Hypertension Reviews

Volumn 2, Issue 3, 2006, Pages 247-253

  Zeng, Chunyu ^a   Eisner, Gilbert M ^b   Felder, Robin A ^c   Jose, Pedro A ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Dopamine receptor; Essential hypertension; G protein coupled receptor kinase; Sodium excretion; Vasorelaxation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; CALCIUM CHANNEL; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; ENDOTHELIN B RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN C FOS; PROTEIN KINASE C; RENIN; SODIUM; SODIUM PROTON EXCHANGE PROTEIN 3; SUBSTANCE P;

ALDOSTERONE RELEASE; DIURESIS; ELECTROLYTE TRANSPORT; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GENE DISRUPTION; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; KIDNEY PROXIMAL TUBULE; NATRIURESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; REVIEW; SIGNAL TRANSDUCTION; SODIUM EXCRETION; TISSUE DISTRIBUTION; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

EID: 33748116768     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340206778132563     Document Type: Review

References (94)

1. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 1998; 80: 149-182.
2. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension 1998; 32: 187-197.
3. Carey RM. Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 2001; 38: 297-302.
4. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000; 62: 621-647.
5. Jose PA, Eisner GM, Felder RA. Dopaminergic mechanisms in the development of hypertension. In: Development of the hypertensive phenotype: Basic and clinical studies. In: McCarty R, Blizard DA, Chevalier RI, editors. Handbook of hypertension, 19. Amsterdam: Elsevier Science; 1999. pp. 1-44.
6. van den Buuse M. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats. Clin Exp Pharmacol Physiol 1998; 25: 661-668.
7. Sowers JR, Viosca SP, Windsor C, Korenman SG. Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men. J Endocrinol Invest 1983; 6: 9-15.
8. Carey RM, Sen S. Recent progress in the control of aldosterone secretion. Recent Prog Horm Res 1986; 42: 251-296.
9. +-ATPase during high-salt diet in young but not in adult rats. Am J Physiol 1998; 275: G13117-G1323.
10. 3 dopamine receptor: Neurobiology and potential clinical relevance. Pharmacol Rev 1997; 49: 231-252.
11. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 1998; 78: 189-225.
12. Glickstein SB, Schmauss C. Dopamine receptor functions: lessons from knockout mice. Pharmacol Ther 2001; 91: 63-83.
13. 3 receptors in the rat kidney: role in physiology and pathophysiology. Acta Physiol Scand 2000; 168: 219-223.
14. 3 receptor gene produces renin-dependent hypertension. J Clin Invest 1998; 102: 493-498.
15. Lokhandwala MF and Amenta F. Anatomical distribution and function of dopamine receptors in the kidney. FASEB J 1991; 5: 3023-3030.
16. Ricci A, Amenta F, Bronzetti E, Felici L, Hussain T, Lokhandwala MF. Age-related changes of dopamine receptor protein immunore-activity in the rat mesenteric vascular tree. Mech Ageing Dev 2002; 123: 537-546.
17. 2-like receptors in the rat kidney: effect of denervation. Eur J Pharmacol 1997; 334: 233-240.
18. 3) as a target for neuroleptics. Nature 1990; 347: 146-151.
19. 3 dopamine receptor gene. Hum Genet 1991; 87: 618-620.
20. 2 subfamily of dopamine receptor genes in the kidney. Am J Physiol 1994; 266: F646-F650.
21. 3 receptor protein in the rat kidney. Hypertension 1998; 32: 886-895.
22. 3 receptor in proximal tubules of the rat kidney. J Histochem Cytochem 2004; 52: 1647-1655.
23. 1 receptor protein in the human heart and kidney. Hypertension 1997; 30: 725-729.
24. 3 receptors in rat juxtaglomerular cells. Clin Exp Hypertens 1997; 19: 93-105.
25. Barili P, Sabbatini M, Soares-da-Silva P, Amenta F. The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 2002; 107: 145-167.
26. 3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 2004; 43: 654-660.
27. 3 dopamine receptor transregulation in hypertension. Hypertension 2004; 43: 673-679.
28. 3 receptor. Mol Pharmacol 1997; 52: 508-514.
29. 3 receptors for the activation of extracellular signal-regulated kinase. J Biol Chem 2004; 279: 28304-28314.
30. Bek MJ, Zheng S, Xu J, et al. Differential expression of adenylyl cyclases in the rat nephron. Kidney Int 2001; 60: 890-899.
31. Stier CT Jr, Cowden EA, Allison ME. Effects of bromocriptine on single nephron and whole-kidney function in rats. J Pharmacol Exp Ther 1982; 220: 366-370.
32. +-ATPase in renal proximal tubules via the cAMP pathway. Eur J Pharmacol 1997; 321: 259-263.
33. 3 receptor functions? Biochem Pharmacol 1996; 52: 511-518.
34. 3 receptor activation modulates renal function in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 1998; 358: 690-693.
35. 3 dopamine receptors in SHRs. Am J Hypertens 2004; 17: 96A. (abstract).
36. Zeng C, Eisner GM, Felder RA, Jose PA. Dopamine receptor and hypertension. Curr Med Chem Cardiovasc Hematol Agents 2005; 3: 69-77.
37. 2-like receptors on renal function. Am J Physiol 1998; 275: R986-R994.
38. Ladines CA, Zeng C, Asico LD, et al. Impaired renal D(1)-like and D(2)-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1071-R1078.
39. +-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol Renal Fluid Electrolyte Physiol 1990; 259: F924-F928.
40. +)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature 1990; 347: 386-388.
41. Satoh T, Cohen HT, Katz AI. Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids. J Clin Invest 1993; 91: 409-415.
42. 4 receptor expression in rat kidney: evidence for pre- and postjunctional localization. J Histochem Cytochem 2002; 50: 1091-1096.
43. 4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct. Am J Physiol 1998; 275: F742-F751.
44. Sanada H, Xu J, Watanabe H, Jose PA, Felder RA. Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney. Am J Hypertens 2000; 13: 156A. (abstract).
45. 1 dopamine agonists. Am J Physiol 1993; 264: F1032-F1037.
46. 3 dopamine receptors: Implications for membrane localization and cAMP signaling. Arch Biochem Biophys 2006; 446: 60-68.
47. 2 dopamine receptor family; differential coupling to Gi, Gz, and Gs. Cell Mol Neurobiol 1999; 19: 653-664.
48. 3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am J Physiol Renal Physiol 2004; 287: F1059-F1066.
49. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19: 233-246.
50. 3 receptors and salt-dependent hypertension. J Am Soc Nephrol 2001; 12: 2272-2279.
51. 3 dopamine receptor-mediated regulation of spontaneous secretory activity. J Gen Physiol 2000; 115: 697-706.
52. Yamauchi M, Kobayashi Y, Shimoura K, Hattori K, Nakase A. Endothelium-dependent and -independent relaxation by dopamine in the rabbit pulmonary artery. Clin Exp Pharmacol Physiol 1992; 19: 401-410.
53. 3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanism in transfected CHO cells. J Med Genet 2004; 41: 867-871.
54. 3 receptor gene D3 Dopamine Receptor and Essential Hypertension in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol Psychiatry 2000; 5: 433-438.
55. 3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients. Nephrol Dial Transplant 2004; 19: 1432-1436.
56. 3 receptor gene is not associated with essential hypertension in the Japanese. Med Sci Monit 2002; 8: CR1-CR4.
57. James K, Weitzel LR, Engelman CD, Zerbe G, Norris JM; Framingham Heart Study. Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study. BMC Genet 2003; 4 Suppl 1: S83.
58. Rice T, Rankinen T, Province MA, et al. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation 2000; 102: 1956-1963.
59. 3 receptor activation in spontaneously hypertensive rats. Hypertens Res 2003; 26: 855-861.
60. Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002; 99: 3872-3877.
61. O'Connell DP, Ragsdale NV, Boyd DG, Felder RA, Carey RM. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 1997; 29: 115-122.
62. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001; 345: 1548-1557.
63. Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. J Clin Endocrinol Metab 1989; 69: 1116-1121.
64. 1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol 1999; 34: 191-198.
65. Chatziantoniou C, Ruan X, Arendshorst WJ. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA 1995; 92: 2924-2928.
66. 1 dopamine receptor in renal proximal tubule cells. Am J Hypertens 2002; 15: 11A. (abstract)
67. 3 dopamine receptor in renal proximal tubule cells. Am J Hypertens 2003; 16: 104A. (abstract)
68. 3 receptors. FEBS Lett 1998; 439: 138-142.
69. 3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 1998; 10: 1676-1686.
70. 1 activation. Pharmacol Biochem Behav 1998; 60, 313-319.
71. Uh M, White BH, Sidhu A. Alteration of association of agonist-activated renal D1(A) dopamine receptors with G proteins in proximal tubules of the spontaneously hypertensive rat. J Hypertens 1998; 16: 1307-1313.
72. β regulation of Na-H exchanger-3 activity in rat renal proximal tubules during development. Am J Physiol Regulatory Integrative Comp Physiol 2000; 278: R931-R936.
73. Albrecht FE, Xu J, Moe OW, et al. Regulation of NHE-3 activity by G-protem subunits in renal brush border membranes. Am J Physiol Regulatory Integrative Comp Physiol 2000; 278: R1064-R1073.
74. Tang TS, Bezprozvanny I. Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons. J Biol Chem 2004; 279: 42082-42094.
75. 1 receptor regulation of phospholipase C. Hypertens Res 1995; 18 Suppl 1: S39-S42.
76. 5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 2005; 288: H55-H61.
77. Yasunari K, Maeda K, Nakamura M, Yoshikawa J. Dopamine as a novel anti-migration factor of vascular smooth muscle cells through D1A and D1B receptors. J Cardiovasc Pharmacol 2003; 41 Suppl 1: S33-S38.
78. 3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway. Neurosci Lett 2004; 371: 34-39.
79. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 1987; 252: F39-F45.
80. 3 receptors. J Neurosci 2004; 24: 3344-3354.
81. 3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proc Natl Acad Sci USA 2001; 98: 5258-5263.
82. 3 receptor signaling by modulating the stability of a receptor-filamin-beat-arrestin complex. A case of autoreceptor regulation. J Biol Chem 2005; 280: 12774-12780.
83. Vassileva I, Mountain C, Pollock DM. Functional role of ETB receptors in the renal medulla. Hypertension 2003; 41: 1359-1363.
84. 3 dopamine receptors regulate of ETB receptors in renal proximal tubule cells of spontaneously hypertensive rats. Circulation 2002; 106: II-329 (abstract).
85. Chen C, Lokhandwala MF. Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats. Naunyn Schmiedebergs Arch Pharmacol. 1995; 352: 194-200.
86. Hussain T, Abdul-Wahab R, Kotak DK, Lokhandwala MF. Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension 1998; 32: 1054-1059.
87. Sheikh-Hamad D, Wang YP, Jo OD, Yanagawa N. Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol 1993; 264: F737-F743.
88. Dagnino-Subiabre A, Marcelain K, Arriagada C, et al. Angiotensin receptor II is present in dopaminergic cell line of rat substantia nigra and it is down regulated by aminochrome. Mol Cell Biochem 2000; 212: 131-134.
89. 1 angiotensin receptor in genetic hypertension. Circulation 2003: 108; IV-214. (abstract)
90. Moe OW, Ujiie K, Star RA, et al. Renin expression in renal proximal tubule. J Clin Invest 1993; 91: 774-779.
91. Cheng HF, Becker BN, Burns KD, Harris RC. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 1995; 95: 2012-2019.
92. 1 receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 2002; 282: F19-F25.
93. 3 dopamine receptors in renal proximal tubule cells of spontaneously hypertensive rats. Hypertension 2003; 41: 724-729.
94. 3 receptors. Neuroscience 1999; 91: 911-924.